Our clinical trials provide accurate data to support the efficacy and safety of various treatments within the pharmaceutical, bio-Tech and medical device industries. Our team provides excellent care to our clinical trial participants. When individuals enroll in one of our clinical trials, they shape the future of healthcare. As a perk, participants also gain insight into their disease process.
We provide medical data that will shape the future of your specific disease.
You gain access to unapproved medications for a specific illness as well as access to clinical trial researchers and experts.
You can help speed up the approval of medications and medical devices for your specific disease.
Below are the various diseases indications we are currently targetting. This list is not encompassing. Contact us at (386) 310-7462 or send us an email.
According to WHO, Cardiovascular disease or heart disease is the leading cause of death internationally. Cardiovascular disease is a group of disorders of the heart and blood vessels including coronary heart disease, cerebrovascular disease, rheumatic heart disease, congenital heart disease and more. Those with a history of Heart Disease, heart attack, stroke, heart failure, Arrhythmia, heart valve problems may be diagnosed with Cardiovascular Disease.
Diabetes is a chronic (long-lasting) health condition that affects how your body turns food into energy. Most of the food you eat is broken down into sugar (also called glucose) and released into your bloodstream. When your blood sugar goes up, it signals your pancreas to release insulin.
Osteoarthritis is the most common form of arthritis. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. Although osteoarthritis can damage any joint, the disorder most commonly affects joints in your hands, knees, hips and spine.
RSV study designed to assess the efficacy and safety of EDP-938 compared to placebo in non-hospitalized adults with acute RSV infection who are at high risk for complications (age ≥65 years, congestive heart failure [CHF], chronic obstructive pulmonary disease [COPD], or asthma)
Content Coming soon
Prevention of symptomatic SARS-CoV-2 infection in household contacts of an individual with symptomatic COVID-19
Meningococcal Vaccine formulations in healthy adolescents
(10 to 17 years of age)